Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Drug Discovery Today is Scopus-indexed (Q1, CiteScore 16.8), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Ltd.
Checked against the index lists dated .
ISSN 1359-6446Verify ISSN ↗1878-5832Verify ISSN ↗
Publisher: Elsevier Ltd
Cost to publish: About US$4,720 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Drug Discovery | 6 / 161 | 96th | Q1 |
| Pharmacology | 12 / 328 | 96th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1996–present, best quartile Q1, CiteScore 16.8.
Drug Discovery Today is Q1 in Drug Discovery (rank 6 of 161) and Q1 in Pharmacology (rank 12 of 328), by CiteScore 2025.
Drug Discovery Today is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 16.8, which places it in quartile Q1 at the 96th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.927, quartile Q1, with an H-index of 235.
The publisher lists an article processing charge of about US$4,720 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Drug Discovery Today is published by Elsevier Ltd. Its print ISSN is 1359-6446 and its online ISSN is 1878-5832.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Drug Discovery Today has an h-index of 250 and a 2-year mean of 8.66 citations per paper (OpenAlex). Its Scopus CiteScore is 16.8, quartile Q1. On 2-year citations it ranks #7 of 159 Scopus journals in Drug Discovery.
Drug Discovery Today published 285 papers in 2025; its busiest recent year was 2021 with 326. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2026), authors are most often from United States (17.9%), China (14.7%) and India (11.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 5 retracted papers are recorded (0.6 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.